We are live on ! Find out more
CK

Carnick & Kubik Portfolio holdings

AUM $334M
1-Year Est. Return 1.52%
This Fund
S&P 500
This Quarter Est. Return
-6.12%
1 Year Est. Return
+1.52%
3 Year Est. Return
+45.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$143M
AUM Growth
+$20.4M
Cap. Flow
+$30.7M
Cap. Flow %
21.48%
Top 10 Hldgs %
21.77%
Holding
421
New
304
Increased
72
Reduced
23
Closed
13

Top Buys

Rank Stock Value
1
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$1.61M
2
SCHM icon
Schwab US Mid-Cap ETF
SCHM
+$1.54M
3
VTIP icon
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
+$1.35M
4
QDF icon
FlexShares Quality Dividend Index Fund
QDF
+$1.31M
5
BNDX icon
Vanguard Total International Bond ETF
BNDX
+$1.28M

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$2.05M
2
ELV icon
Elevance Health
ELV
+$1.37M
3
UNP icon
Union Pacific
UNP
+$1.32M
4
WEC icon
WEC Energy
WEC
+$1.21M
5
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$1.21M

Sector Composition

Rank Sector Weight
1 Healthcare 12.69%
2 Technology 8.46%
3 Consumer Discretionary 6.79%
4 Communication Services 6.32%
5 Financials 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARWR icon
401
Arrowhead Research
ARWR
$12.1B
$432 ﹤0.01%
+75
New +$472
CASC
402
DELISTED
Cascadian Therapeutics, Inc.
CASC
$411 ﹤0.01%
+25
New +$513
VIVS
403
VivoSim Labs
VIVS
$1.46M
$402 ﹤0.01%
+1
New +$759
TIVO
404
DELISTED
Tivo Inc
TIVO
$399 ﹤0.01%
+38
New +$460
NAVB
405
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$342 ﹤0.01%
+8
New +$302
AXN
406
DELISTED
Aoxing Pharmaceutical Company Inc.
AXN
$222 ﹤0.01%
+150
New +$236
ATR icon
407
AptarGroup
ATR
$8.45B
– –
-8,315
Closed -$530K
BA icon
408
Boeing
BA
$165B
– –
-14,550
Closed -$1.2M
BRK.A icon
409
Berkshire Hathaway Class A
BRK.A
$1.07T
– –
-1,000
Closed -$2.05M
CLX icon
410
Clorox
CLX
$11.6B
– –
-5,635
Closed -$633K
CM icon
411
Canadian Imperial Bank of Commerce
CM
$107B
– –
-12,780
Closed -$471K
DFS
412
DELISTED
Discover Financial Services
DFS
– –
-16,159
Closed -$931K
ELV icon
413
Elevance Health
ELV
$81.9B
– –
-8,322
Closed -$1.37M
GILD icon
414
Gilead Sciences
GILD
$161B
– –
-9,003
Closed -$1.05M
MCHP icon
415
Microchip Technology
MCHP
$42.8B
– –
-40,510
Closed -$961K
MGA icon
416
Magna International
MGA
$17.9B
– –
-17,866
Closed -$1M
RCL icon
417
Royal Caribbean
RCL
$78.7B
– –
-15,316
Closed -$1.21M
WEC icon
418
WEC Energy
WEC
$37.7B
– –
-26,920
Closed -$1.21M
VIAB
419
DELISTED
Viacom Inc. Class B
VIAB
– –
-8,405
Closed -$543K
13 14 15 16
17

Similar funds

HC
HHG & Company Darien, Connecticut $360M AUM 2.44% 1-Year Est. Return
FVFI
Flagship Ventures Fund IV Cambridge, Massachusetts $382M AUM
IUAM
Itau USA Asset Management New York $410M AUM 3.05% 1-Year Est. Return
SAS
Spectrum Advisory Services Atlanta, Georgia $255M AUM 4.81% 1-Year Est. Return
GWM
Gupta Wealth Management San Diego, California $427M AUM 0.52% 1-Year Est. Return
SHG
Seven Harbour Global New York $235M AUM
ACM
Andor Capital Management Rye Brook, New York $232M AUM 22.72% 1-Year Est. Return
SCM
Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

Carnick & Kubik's Q3 2015 Portfolio in Review

As of Q3 2015, Carnick & Kubik held 421 positions worth $143M, up 17% from $122M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Carnick & Kubik deployed $30.7M of net new capital in Q3 2015, opening 304 new positions and adding to 72 existing holdings. Its largest new stake was Schwab US Dividend Equity ETF: 129,276 shares worth $1.55M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Union Pacific, an estimated $1.32M trimmed.

  • Carnick & Kubik's largest Q3 2015 buy was Schwab US Dividend Equity ETF: 129,276 shares worth $1.55M.
  • Carnick & Kubik added most to Lowe's Companies in Q3 2015, an estimated $1.08M increase.
  • Carnick & Kubik's biggest Q3 2015 reduction was Union Pacific, cutting an estimated $1.32M.
  • Carnick & Kubik fully exited Berkshire Hathaway Class A in Q3 2015, selling an estimated $2.05M.
  • Carnick & Kubik's ten largest holdings make up 22% of its $143M portfolio in Q3 2015.
  • Carnick & Kubik opened 304 new positions and closed 13 in Q3 2015.
  • Carnick & Kubik's portfolio value rose 17% quarter-over-quarter to $143M.

Based on Carnick & Kubik's 13F filing for Q3 2015, filed 13 Nov 2015.